Therapeutic effects of manual therapy, transcutaneous electric nerval stimulation und forearm (extensor) brace on lateral epicondylopathia - a randomized controlled trial
- Conditions
- M77.1Lateral epicondylitis
- Registration Number
- DRKS00021137
- Lead Sponsor
- Praxis für Allgemeinmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 52
Patients were included in the order they appeared at the practice with no pre-selection if they met the following criteria: (1) age between 18 and 65 years, (2) criteria for the diagnosis of a lateral epicondylitis needed to be fulfilled, (3) informed consent was given. Lateral epicondylopathia was diagnosed if (1) pain was reported for the lateral region of the elbow, (2) an extension of the hand joint provoked significant pain (provocation test), and (3) other diseases or injuries were excluded.
Patients were excluded from the study if they met at least one of the following criteria: injuries reported for the arm or cervical spine during the last 6 months, acute or chronic infections, rheumatic diseases, osteochondrosis dissecans, advanced osteoarthritis in the elbow, pregnancy, diabetes, malignoms, medication with beta blockers, medication with statins, malformation in upper extremities, circulatory disorder in upper extremities, radicular syndrome (C 6), chronic pain syndrome, manifest psychiatric disorder, neuropathy, myopathy.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcomes were measured: Pain with VAS (visual analogous scale) and Range of Motion (ROM) of of the elbow joint in degrees before treatment (0) and in three follow ups 4, 8 weeks and 1 year later
- Secondary Outcome Measures
Name Time Method Secondary Outcomes were measured: Pain and Range of Motion with PRTEE (Patient Rated Tennis Elbow Evaluation Questionnaire) and psychosocial well-being with the Sf 36 (Short form 36 Questionnaire) before treatment (0) and in three follow ups 4, 8 weeks and 1 year later